Jpmorgan Chase & CO Century Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 71,721 shares of IPSC stock, worth $75,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,721

Previous 20,057 257.59%

Holding current value

$75,307

Previous $51,000 139.22%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	BUY	$1.44 - $3.29 $74,396 - $169,974	51,664 Added 257.59%	71,721 $122,000
Q3 2024 Nov 08, 2024	BUY	$1.44 - $3.29 $74,396 - $169,974	51,664 Added 257.59%	71,721 $122,000
Q2 2024 Dec 26, 2024	SELL	$2.46 - $4.05 $127,093 - $209,239	-51,664 Reduced 72.03%	20,057 $51,000
Q2 2024 Aug 12, 2024	SELL	$2.46 - $4.05 $13,832 - $22,773	-5,623 Reduced 21.9%	20,057 $51,000
Q1 2024 Dec 26, 2024	SELL	$3.19 - $5.32 $146,870 - $244,938	-46,041 Reduced 64.19%	25,680 $107,000
Q1 2024 May 10, 2024	BUY	$3.19 - $5.32 $33,488 - $55,849	10,498 Added 69.15%	25,680 $107,000
Q4 2023 Dec 26, 2024	SELL	$1.28 - $3.32 $72,369 - $187,709	-56,539 Reduced 78.83%	15,182 $50,000
Q4 2023 Feb 12, 2024	SELL	$1.28 - $3.32 $14,516 - $37,652	-11,341 Reduced 42.76%	15,182 $50,000
Q3 2023 Nov 14, 2023	BUY	$2.0 - $3.23 $11,614 - $18,756	5,807 Added 28.03%	26,523 $53,000
Q2 2023 Aug 11, 2023	SELL	$2.91 - $3.53 $131,054 - $158,977	-45,036 Reduced 68.49%	20,716 $65,000
Q1 2023 May 18, 2023	BUY	$3.4 - $5.11 $52,451 - $78,831	15,427 Added 30.65%	65,752 $228,000
Q1 2023 May 11, 2023	SELL	$3.4 - $5.11 $51,462 - $77,344	-15,136 Reduced 23.12%	50,325 $174,000
Q4 2022 Feb 13, 2023	BUY	$4.84 - $11.58 $11,422 - $27,328	2,360 Added 3.74%	65,461 $335,000
Q3 2022 Nov 14, 2022	SELL	$8.57 - $13.1 $19,325 - $29,540	-2,255 Reduced 3.45%	63,101 $624,000
Q2 2022 Aug 11, 2022	BUY	$7.96 - $12.43 $49,646 - $77,525	6,237 Added 10.55%	65,356 $548,000
Q1 2022 May 11, 2022	SELL	$11.62 - $15.92 $950,911 - $1.3 Million	-81,834 Reduced 58.06%	59,119 $744,000
Q4 2021 Feb 10, 2022	BUY	$13.93 - $23.62 $1.08 Million - $1.83 Million	77,529 Added 122.24%	140,953 $2.24 Million
Q3 2021 Nov 12, 2021	BUY	$20.8 - $31.93 $1.32 Million - $2.03 Million	63,424 New	63,424 $1.6 Million

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Century Therapeutics, Inc. Transaction History